Last day of trading in paid subscription shares (BTA 2) of

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

MacKenzie Scott's Generous Contribution to Morgan State University In an amazing show of support for higher education, philanthropist MacKenzie Scott has made headlines by donating a remarkable $63 million to Morgan State University. This gift marks her second significant contribution to the University in just five years, further solidifying Morgan's status as a rapidly...

Avient Corporation Declares Quarterly Dividend for 2025 Avient Corporation (NYSE: AVNT), a leader in innovative materials solutions, has recently made an important financial announcement. The Board of Directors has declared a quarterly cash dividend of 27 cents ($0.27) per share for its common stock. This move reflects Avient's commitment to providing returns to its...

KBRA Assigns Preliminary Ratings to Oceanview Mortgage Trust 2025-INV1 KBRA has recently assigned preliminary ratings to a total of 72 classes of mortgage-backed securities associated with Oceanview Mortgage Trust 2025-INV1 (BVINV 2025-1). This notable transaction is entirely backed by prime, investment-purpose mortgage loans, reflecting the company’s commitment to...

HD Hyundai's Strategic Move for Growth In a significant step towards expanding its global footprint, HD Hyundai has signed an exclusive business agreement with the Tamil Nadu state government to establish a new shipyard. This partnership aims to leverage the region's favorable climate and other conditions, mirroring those of Ulsan, Korea, where HD Hyundai Heavy Industries...

Alumis Finalizes Strategic Merger with ACELYRIN In a significant development, Alumis Inc. (Nasdaq: ALMS), a biopharma company specializing in innovative therapies for immune-mediated diseases, has officially completed its merger with ACELYRIN, Inc. This merger marks a pivotal moment for Alumis as it strengthens its position in the biopharmaceutical industry. Details of...